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Abstract
The enzyme Polyphosphate Kinase (PPK) catalyses the reversible transfer of the terminal c-Pi of ATP to form a long chain
Polyphosphate (PolyP). Using an IPTG inducible mycobacterial vector, the vulnerability of this gene has been evaluated by
antisense knockdown experiments in M. tuberculosis. Expression profiling studies point to the fact that down regulation of
PPK caused cidality during the late phase in contrast to its bacteriostatic mode immediately following antisense expression.
PPK thus seems to be a suitable anti-tubercular drug target. The enzyme which is a tetramer has been cloned in E. coli and
purified to homogeneity. An enzyme assay suitable for High Throughput Screening was optimized by using the statistical
Taguchi protocol and the kinetic parameters determined. The enzyme displayed a strong product inhibition by ADP. In
order to accurately estimate the product inhibition, progress curve analysis of the enzyme reaction was monitored. The
kinetic equation describing the progress curve was suitably modified by taking into account the product inhibition. The
reversible nature of the enzyme indicated a possibility of a two way ATP«ADP switch operating in the bacteria as a
response to its growth requirement.
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Introduction
Inorganic Polyphosphate (PolyP), a likely precursor in pre-biotic
evolution, is a ubiquitous entity that is found in diverse locations
such as volcanic condensates, deep oceanic steam vents and inside
living cells. They are linear polymers in the size range of 3–1000 of
orthophosphate residues linked by high-energy phospho-anhy-
dride bonds. Though this polymer was identified more than a
century ago, its biochemical role has only been clarified in the last
decade through the pioneering work by Kornberg and colleagues
[1–4].
In nature, polyphosphate is formed by dehydration of
orthophosphate at elevated temperature, while its cellular synthesis
is catalyzed by the enzyme Polyphosphate Kinase (PPK) which
uses the c-Pi of ATP to extend the polymer. Its reverse reaction is
the formation of ATP from ADP and Pi [2]. Although this
polymer is found in nearly all types of bacteria, its level fluctuates
orders of magnitude depending on the physiologic and metabolic
state of the cell. Its cellular accumulation is in response to specific
physiological states - like deficiencies in amino acid, Pi, nitrogen or
to the more general stresses akin to a nutrient downshift or high
salt. It seems that the intracellular polyphosphate level is
maintained by shifting the equilibrium between the forward and
the reverse rate of the enzyme reaction. An interesting observation
has been the stage specific essentiality of the gene. Mutants of E.
coli (ppk
2) have severe growth defects in the stationary phase while
showing normal growth kinetics in the logarithmic zone.
Stationary phase of growth as studied in the laboratory can be
thought of resembling the stressful and deprived state that
characterizes the natural habitat of most bacteria. To cope with
such adverse conditions, stationary phase cells undergo drastic
physiological and morphological changes and a number of genes
are induced in this phase in order that the cells survive [5].
Localization of PolyP granules in the vicinity of bacterial
nucleoid suggests their possible involvement in regulation of gene
activity, which may be essential for adaptation to stationary phase
and other stresses [6]. Thus, not only polyphosphate could act as
an essential marker for stress response, but it also might supply the
organism of the much needed ATP to cope during its nutrient
downshift or environmental stress. Additionally, the phosphoan-
hydride bonds can be used as a high energy source for
phosphorylation of glucose as its free energy of hydrolysis is
almost equal to that of ATP. PPK has also been implicated in
virulence and in-vivo growth in several bacteria. In view of the
phylogenetic similarity of the enteropathogens and the frequency
with which virulence factors are expressed in stationary phase,
mutants lacking the ppk gene in pathogenic Shigella flexneri,
Salmonella enterica serovar dublin, and Salmonella enterica serovar
typhimurium showed decreased virulence phenotype such as: (i)
growth defects, (ii) defective responses to stress and starvation, (iii)
loss of viability, (iv) polymyxin sensitivity, (v) intolerance to acid
and heat, and (vi) diminished invasiveness in epithelial cells. A ppk
mutant of Pseudomonas aeruginosa was shown to be defective in
quorum sensing and the dependent virulence factors, elastase and
rhamnolipid; the mutant was also deficient in biofilm formation
and was not lethal in a burned-mouse pathogenesis model [7].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14336Vibrio cholerae ppk mutants show defects in growth, motility, and
surface attachment, features linked to virulence [8,9].
Of all the pathogenic bacteria M. tuberculosis stands out as the
most successful example of survivability under in-vivo and in-vitro
stress. In a landmark experiment by Corper and Cohn in 1920, it
was shown that sealed cultures of TB bacilli at 37uC was viable
(ranging from 0.1% to 1%) even after 12 years [8]. It is of interest
to note that the bacilli are adept at withstanding insults such as
desiccation, nutrient deprivation and osmotic shock. Also the in-
vitro stationary state grown bacilli and the one directly derived
from mouse lung are able to survive heat exposure at 53uC much
better that the logarithmic phase grown bacteria [10].
The persistent tubercular bacilli in the human host are often
impervious to standard anti-TB drugs which are generally focused
on the rapidly dividing phase of the organism. Thus making the
treatment of TB, in its short term version of six months, the longest
among all anti-infectives. We postulate that PPK in M. tuberculosis
could be one of the key enzymes that harness the bacteria to
survive the onslaught of stress and nutritional downshift and persist
in the in-vivo milieu evading the immune system. Potent inhibitors
of M.tu PPK when combined with the standard anti-TB regimen
may thus be able to substantially reduce the duration of therapy.
An anti-mycobacterial drug targeted against PPK should also
show selectivity and less toxicity, as the enzyme has not been found
in mammalian cells. To test this hypothesis conditional induction/
knockdown strategies can be used to simulate altered physiological
states and one could measure the resulting effects, be metabolic
changes or survival characteristics. A crucial index of a target gene
is whether its inhibition leads to stasis or cidality. We have recently
reported the down regulation of various anti-tubercular target
genes using inducible anstisense RNA technology [11]. It would be
interesting, given the biochemical understanding of PPK, to
investigate into the survival kinetics of M. tuberculosis following
knockdown of ppk.
The aim of the present study was to observe the effect of
modulation of ppk and evaluate its viability as a drug target. If
Figure 1. Knockdown of PPK in M. tuberculosis. (a) ppk antisense under IPTG inducible promoter was transformed. The transformants were
divided equally and plated under various concentration of IPTG (0–1000 uM) (b) ppk antisense were induced in cultures at various IPTG
concentration (0–1000 uM) in a liquid culture. It was plated for cfu enumeration of the survivors after various time intervals.
doi:10.1371/journal.pone.0014336.g001
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biological role and inhibitor screening.
Results
Vulnerability of PPK in M. tuberculosis
Antisense expression of ppk clearly shows that the gene is
essential in M. tubercuolsis (Figure 1). Whereas the antisense
transformants in the plates show confluence in absence of the
inducer IPTG, there was only a single colony at the maximum
inducer concentration of 1 mM. The intermediate concentration
of IPTG show graded number of transformants indicating a dose
response (Figure 1a). Though it is difficult to quantify the level of
knockdown of gene expression following antisense expression, the
qualitatively proportional relationship between IPTG concentra-
tion and cfu indicated, that so far as the growth of the bacteria in
an agar media is concerned, the gene was vulnerable. This
indicated that a moderate down regulation of the gene expression
inhibited the growth. The effect of antisense expression in the
liquid media showed somewhat different response (Figure 1b). Till
15 days following the antsisense expression there was only a
marginal drop in cfu. However in the next 15 days there was 3–4
log reduction in the cfu indicating a steep bactericidal dose
response. This drop compared favorably with our earlier
observation of 2–3 log drop in cfu with proven antitubercular
targets like rpoB, gyrA/B and inhA [11]. That these effects
were not compounded by the long term plasmid stability were
verified in an independent experiment. It was seen that the
plasmid pAZI9018b was stable in mycobacteria even in the
absence of antibiotic pressure for over two months (data not
shown).
Fold changes in the expression of M. tuberculosis ppk
during different phases of growth
The expression profile of ppk indicated that compared to the
constitutive gene SigA, ppk is over expressed in the log phase and
there is approximately a ten fold down regulation in the stationary
phase (Table 1). This is in alignment with the level of ATP during
these phases. We speculate that the forward reaction is
predominantly operative during the log phase while the reverse
is operative during the stationary phase. A recent data indicate
that the FoF1 ATPase inhibitor TMC 207 was inactive in the
stationary phase though it had less (five fold) ATP [12]. This data
apparently looks counterintuitive, however in light of our
hypothesis that ATP is generated, primarily through reverse
PPK activity from polyphosphate and ADP in stationary bacteria,
it seems logical for TMC207 to loose its potency in the stationary
phase. We observed that the level of ppk transcript in the stationary
phase antisense strain was twice the level of wild type strain
(Table 1). It should be noted that we had done a single tube RT-
PCR where both the primers (forward and reverse) are present.
This would imply that both sense and antisense transcript would
be equally amplified. The fact that the concentration of the ppk
transcript in the stationary phase antisense strain was twice the
level of wild type strain would indicate that in the former both the
sense and the antisense are in equal amount while in the wild type
only the sense mRNA was transcribed. That the concentration of
sense and antisense transcripts were equal would indirectly
indicate that they form a 1:1 hybrid. Additionally, we could not
see any amplification in the wild type RTPCR when using the
forward primer in the reverse transcriptase assay (data not shown).
This indicated that the antisense transcript is only produced in the
strain harboring the antisense construct.
Cloning, expression and Purification of PPK
The standard 37uC expression of PPK with clone pAZ1 or pAZ2
generated largely inclusion bodies. However soluble expression was
achieved by changing the growth temperature from 37uCt o2 0 uC.
Induction with IPTG was also not required. Overnight growth at
20uC enhanced expression of PPK in the soluble form. Fortunately,
the initial step of Ammonium sulphate fractionation (35% v/v)
resulted in 60–70% pure protein. Anion exchange Chromatogra-
phy through Mono-Q resulted in producing recombinant M. tu
PPK with purity of approximately 95% and with a mass of 81 kD
on SDS-PAGE (Figure 2). In the native state the protein appeared
as a tetramer in gel-filtration chromatography (Text S1) similar to
that reported in E. coli [13]. Similar quality of protein resulted from
Ni-affinity column for the his-tagged protein.
Metachromatic assay for PPK
The metachromatic dye, Toluidine blue has been previously
shown to be effective for the quantification of PolyP [14] and has
thus been the method of choice for PPK assay. PolyP being
polyanionic induces a shift in the absorption spectrum of toluidine
blue from 630to 530 nm.Thisshift is proportionalto concentration
of PolyP provided its chain-length is greater than 15 residues. The
intensity of the absorption change varies not only with PolyP
concentration but with the average chain-length. The latter effect
can be minimized by employing PolyP of standard lengths in which
Table 1. Fold changes in the expression of M. tu ppk in
different growth phases.
Log phase
(5 days)
Stationary
phase
(28 days)
Stationary
phase
(63 days)
Antisense
(63 days)
Sig A 1.0160.17 0.9960.08 1.0060.14 1.0160.23
ppk 28.862.3 2.4560.28 2.960.15 5.3561.08
doi:10.1371/journal.pone.0014336.t001
Figure 2. SDS-PAGE analysis of purified PPK. Samples of PPK after
purification were analyzed by SDS-PAGE (10%) and visualized by
Coomassie blue staining; lane 1- PPK His-tagged (purified using Ni-NTA),
lane 2- PPK untagged (purified using Mono-Q), lane 3- MW marker
(Biorad-6H).
doi:10.1371/journal.pone.0014336.g002
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fashion [15]. To overcome these problems we adopted an
alternative approach for the direct measurement of PolyP
concentration. The approach involved the use of the Isosbestic
Point that was observed when Toluidine blue bound to PolyP
(Figure 3).The isosbestic wavelength was found to be in the range of
550–560 nm. A range, because like in many instances, isosbestic
wavelength was found to vary with slight changes in pH and
temperature [16]. The extinction co-efficient of Toluidine blue
(unbound) was found to be 24000/M/cm [17]. Using this
information, the concentration of bound dye was determined. To
ascertain PolyP concentration, the knowledge of the stoichiometry
of the binding of dye to PolyP was essential. This was determined
indirectly by measurements of association constant Ka between the
dye and polyP of various length (Table 2). The intercept of Btotal/
Bfree vs [P] plot was one and independent of the length of the PolyP,
indicating 1:1 stoichiometry between PolyP and toluidine blue.
Optimization of PPK activity by Taguchi Protocol
As stated earlier, the assay conditions were optimised by the
Taguchi method (Figure S1). The dependence of activity on
divalent cation(Mg
2+) was similar tothat described forPPKof other
organisms. Optimum Mg
2+concentration was found to be 5 mM.
PPK activity decreased with increasing concentrations of ammoni-
um sulphate. However we used 10 mM Ammonium sulphate.
Optimum salt concentration (NaCl) was found to be 75 mM. With
increase in PolyP primer, the activity increased, but to reduce the
background signal, 40 nM of PolyP-Type 6 was used. Further
investigation ofPPKactivity revealed an optimum pH of7.0(Figure
S2).TherequirementofpolyPprimerwasabsoluteforPPKactivity.
Kinetic Parameters
Kinetic analysis of PPK activity indicated a Km of
approximately 40 uM as interpolated from the Hanes–Wolf plot
(Figure 4). Vmax was found to be 0.56 nmole of Pi/min/mg
protein. Assay with the His-tagged protein revealed similar value
for Km but a lesser Vmax (20–30% less) than the untagged PPK
(data not shown). The lower Vmax can be attributed to the
presence of Hexa histine-tag at C-terminal end.
HPLC assay for PPK activity
In addition to the metachromatic assay, we also used HPLC to
measure ADP the other product formed in the reaction. In the
reverse reaction PPK catalyzed the formation of ATP which was
also monitored by HPLC. Using the stated buffer conditions we
were able to resolve both ATP and ADP as two separate peaks,
with retention time of 23.7 mins and 21.82 mins respectively. The
Km for ATP in the forward reaction was found to be 800 uM.
The large difference in the Km for ATP in the HPLC assay
compared to the metachromatic method was due to the presence
of product inhibition in the former which is neutralized in the
latter by regenerating ATP with the aid of PEP and Pyruvate
Kinase. Km for ADP in the reverse reaction was found to be
approximately 100 uM (Table 3) and Vmax for the reverse
reaction was found to be 0.04umolePi/min/mg protein.
Evaluation of Product inhibition by progress curves
Though a powerful tool in enzyme kinetics, progress curve finds
limited use in enzymology due to the problem that arises due to
Figure 3. Assay for PPK activity at varying time intervals. Polyphosphate synthesis by PPK at varying time-intervals (0–15 min) was done at
37uC for 10 min and was monitored by the metachromatic assay. 1.2 ug enzyme was used for 30 ul reaction. The absorption spectra clearly shows
the presence of Isosbestic Point (550 nm).
doi:10.1371/journal.pone.0014336.g003
Table 2. Association constant – Ka, for binding between
Toluidine blue of PolyP.
Type of Poly P Association constant Ka (M
21)
Type 6 0.6610
6
Type25 2.61610
6
Type 45 3.85610
6
Type 65 24.77610
6
doi:10.1371/journal.pone.0014336.t002
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Km of ATP in the two methods (Toluidine blue and HPLC) is due
to a strong product inhibition by ADP. When the product and the
substrate compete in the same space the progress curve is given by
equation2. Using this kinetics the Kp of ADP was determined to
be 26 uM. As postulated at various substrate values, parallel lines
with similar slope and variable intercepts were obtained. Since
Km, Vmax and substrate concentration was known, Kp was
estimated accurately. The plot of p/[lns/(s-p)] versus t/[lns/(s-p)]
indicated parallel lines for ATP concentration of 100 uM and
200 uM (Figure 5). By representing dual ordinate axis the parallel
lines were shown to be overlapping.
Discussion
PolyP has been detected in many organisms and is found to be
commonly present as intracellular inclusions [18]. All the presently
available data clearly indicate that PolyP plays a significant role in
cellular metabolism and is really as described a ‘‘molecule for
many purposes’’ in the cell [19].
Understanding the metabolic role of M.tu PPK would be
interesting due to its several discrete functions. PPK’s essential
function in the stationary phase and its requirement for virulence
has been shown in many organisms. The facile reversibility of the
enzymatic activity of PPK may indicate that the balance between
the forward and reverse reaction via a dynamic interplay between
the Km of ATP and Kp of ADP might tilt the balance of the
reaction one way or the other, thus providing a unique two way
energy switch. This may be helpful in explaining its linkage with
respect to the prolonged dormancy and its possible role in helping
the bacilli while sustaining stress and nutritional deprivation. Our
results indicate that a down regulation of the gene expression by
antisense constructs results in bactericidal activity. However there
is an important temporal factor that is incorporated. In the liquid
culture down regulation of ppk results in stasis for about 15 days.
This is followed by a rapid cidal phase. Rapid cidality associated
Figure 4. Hanes-Woolf plot for Km determination of ATP (forward assay). The Km for ATP was determined by the metachromatic assay by
doing the experiment at different concentrations of ATP (12.5–400 uM) using 1.2 ug of enzyme.In this plot [S]/v is plotted against [S]. A straight line
of slope 1/V max with intercepts –Km and Km/V on the abscissa and ordinate respectively is obtained.
doi:10.1371/journal.pone.0014336.g004
Table 3. Kinetic constants of M. tu PPK.
Kinetic constant Toluidine Blue Assay (Forward assay) HPLC Assay (Forward assay) HPLC Assay (Reverse assay)
Km 40 uM 800 uM 100 uM
Kp -2 6 u M -
The Km for the forward reaction (formation of PolyP) was determined by both the methods (Metachromatic method and HPLC). The high Km seen in case of the HPLC
method is due to ADP inhibition as the ATP-regenerating system of PEP and PK is absent in the assay. The reverse reaction was monitored only by HPLC method.
doi:10.1371/journal.pone.0014336.t003
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days) correlates well with the reduction of ATP during late phase
of growth. Decline in net ATP levels and a concomitant reduction
of atpE mRNA encoding ATP synthase has been shown to be
physiologically linked with growth phase of bacteria as well as by
chemically blocking ATPase activity of mycobacteria [20].
Additionally, anaerobic M. tuberculosis cultures in the Wayne
model at day 18 had reduced atpE mRNA expression and 10 fold
less ATP levels compared with aerobic logarithmically growing
cultures [20]. Wayne et. al. 1996 [21] have previously shown that
total cellular ATP levels in dormant M.tu are significantly lower
compared with replicating bacteria. [21]. Therefore, it appears
that bacteriostatic effect of our antisense construct in actively
replicating phase in the first 14 days was due to presence of higher
ATP levels while sharp bactericidal activity seen at day 14
onwards following antisense downregulation of ppk may be related
to low ATP levels during late stage of growth thus making
mycobacteria more vulnerable in this phase. This was confirmed
by our data on the expression levels of Mtu ppk in different growth
phases (Table 1) which states that as compared to the constitutive
gene SigA (Rv2703) [22], Mtu ppk (Rv2984) is over expressed in the
log phase and there is approximately a ten fold down regulation in
the stationary phase (Table 1). This is in alignment with the level
of ATP during these phases. We speculate that the forward
reaction is predominantly operative during the log phase and
polyphosphate is generated. In contrast, the reverse reaction is
operative during the stationary phase to synthesize ATP. A recent
data indicates that the FoF1 ATPase inhibitor TMC 207 was
inactive in the stationary phase though it had less (five fold) ATP
[12]. This data apparently looks counterintuitive. However in light
of our hypothesis that in stationary bacteria ATP is primarily
generated through reverse PPK activity from polyphosphate and
ADP and not through FoF1 ATPase, it seems logical for TMC207
to loose its potency in the stationary phase.
These results thus can be understood in light of the efficient
reversibility of PPK. Compared to log phase, the vulnerability of
ppk is even more pronounced in the stationary phase in M.
tuberculosis. This adds another vulnerable/cidal target to the list of
cidal/static mycobacterial targets recently validated by antisense
down regulation [11]. It is interesting to note that in M. smegmatis,
the rapidly growing mycobacteria ppk is not essential as the
knockout could be generated [23]. Our results to generate
knockout in M. tuberculosis were unsuccessful even in present of a
complemented plasmid. These results are strongly indicative of the
stage specific essentiality of this gene in M. tuberculosis. It has
recently been shown that in E. coli, bactericidal activity of various
antibiotics proceed through a common mechanism of free radical
generation which leads to the upregulation of a common set of 38
genes including ppk [24]. It thus seems logical that down regulation
of ppk would lead to cidality in M. tuberculosis. Recently a putative
class II polyphosphate kinase designated as PPK 2 has been
identified in mycobacteria [25]. It was seen that PPK2 catalyzes
the synthesis of GTP from GDP using polyP rather than ATP as
phosphate donor. This data indicated that PPK2 could not
biochemically complement PPK1 [25].
A pre-requisite for PPK to be a validated drug target in M.
tuberculosis, is the elucidation of its role in survival of the bacteria in-
vivo, especially during the latent phase, and finally in the human
host. The fact that this gene is absent in human brings in a unique
selectivity. The biochemical pathways in M. tuberculosis that are
involved in latency are still elusive. But it seems logical that PPK
due to its facile reversibility and its stage specific essentiality would
turn out to be a prime candidate. Our understanding is that PPK
in the log phase does the non essential role of synthesizing
polyphosphate utilizing the excess of ATP. In the non replicating
phase (stationary, dormant or latent) it does the essential role of
producing ATP from the stored polyphosphate. Our detailed
kinetic analysis of this reaction supports this hypothesis. Finally we
have also developed the Toluidine blue assay for monitoring the
PolyP concentration by bringing in the observed phenomenon of
Isosbestic point. This assay has been suitably converted to a high
throughput microtitre plate format that is suitable for screening
potential inhibitors. The selectivity of these inhibitors would be in
contrast to TMC207, PPK inhibitors would be cidal in the
stationary phase. Molecules that induce cidality in non replicating
mycobacteria would be a key component in combination
antitubercular therapy.
Materials and Methods
Antisense ppk (ppk-AS) in M. tuberculosis
To test the vulnerability (survivability under down regulation) of
ppk, the full length gene (Rv2984 from M. tu. annotated as ppk in
KEGG) was cloned in antisense orientation in the IPTG inducible
mycobacterial shuttle vector pAZI9018b [11] in the BamHI and
NdeI site. The ppk antisense clone was transformed into M.
tuberculosis by electroporation and equal amount of transformants
were plated at various concentration of IPTG (ranging 0, 10, 100
and 1000 uM). Transformants growing in uninduced plates were
grown to about 10
7 cfu/ml and antisense ppk expression was
induced by IPTG (ranging from 0 to 1000 uM). Survivability of
the bacilli during a five week period (,35 generations) was
monitored in triplicate by plating for colony forming units (cfu).
Details of the transformation and survival kinetics are discussed
earlier [11].
Regulation of M. tuberculosis ppk gene expression during
different phases of growth
An M. tuberculosis culture grown in 7H9 complete medium (with
0.05% Tween and ADC supplement) was harvested in log phase (5
days), late log/early stationary phase (28 days) and late stationary
Figure 5. Progress curves for the determination of Kp. The data
for the assay done at an ATP concentration of 100 and 200 uM, at time
intervals 3, 6, 9, 12, 15 min are plotted as shown. The double ordinate
plot shows that the two sets of data form a parallel line. Using the
intercept in each case, Kp was calculated. Km and Vmax values were
taken from the Toluidine Blue assay.
doi:10.1371/journal.pone.0014336.g005
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e14336phase (63 days). One ml of TrizolH was added to the cell pellets
(from 5 ml culture) to stabilize and arrest the mRNA. Cells were
disrupted by bead beating using 0.1 mm diameter zirconium
beads (Biospec), followed by a 5 min centrifugation at 14,000 g.
Total RNA was isolated and prepared for transcriptome analysis
by qRTPCR as reported earlier [11]. Expression level of Mtu ppk
(Rv2984) was estimated in comparison to the house-keeping gene
Mtu sigA (Rv2703) in different phases of growth [22]. RTPCR was
performed in quadruplicate using SYBR Green chemistry and
data was analyzed as reported [11]. The primers used for this
assay were: sigART(F) 59-TCGAGGTGATCAACAAGCTG-39,
sigART(R) 59-CTGCAGCAAAGTGAAGGACA-39, ppkRT(F)
59-. TTACAACAGC AAGACAGCACG-39, and ppkRT (R) 59-
CATCAACAAGGGCATTCATCT-39.
Construction of recombinant PPK clones
The gene Rv2984 from M. tu. was amplified using the primers
ppk-F (59atgagcaatgatcgcaaggtg 39) and ppk-H (59cccaagcttgg-
ggctgcggtgccgttccatc 39). The amplified product was digested with
HindIII and was cloned into NcoI blunt-HindIII site of pET-21d
(Amp
r, C-terminal hexa His-tag) to form pAZ-2 clone. The clones
were confirmed by DNA sequencing. For the cloning of untagged
ppk, the gene cloned in pET-21D was amplified with a stop codon
and recloned cloned in the same vector to form pAZ-1.
Reagents
Pyruvate kinase, ATP, PolyP (Type 6, 25, 45, 65, 75), Toluidine
blue and IPTG were procured from Sigma Chemicals, restriction
enzymes from New England Biolabs and Bangalore Genei (India).
PCR was done using Expand polymerase from Roche.
Strains
Strains used were E. coli MOS blue, E. coli BL-21(DE3) and M.
tuberculosis H37Rv ATCC 27294.
Purification of recombinant M. tu PPK
E. coli BL-21 (DE3) cells transformed with pAZ (1 or 2) clones
were grown in 500 ml LB (100 ug/ml ampicillin) at 37uC till 0.6
O.D600 after which the cells were downshifted and grown at 20uC
O/N for 16 hrs. to achieve soluble overexpression of PPK.
Induction by IPTG was not required. Harvested cells were
suspended in 1/10
th culture volume of Buffer A (250 mM Tris,
pH-7.5, 1 mM PMSF, 1 mM EDTA, 1 mM DTT, 10% glycerol)
and lysed by sonication till O.D600 reached 1/10
th the initial O.D.
The homogenate was spun at 50,0006 g for 30 mins to remove
cell-debris.
The lysate was then subjected to ammonium sulphate
precipitation (35% v/v) by addition of appropriate volume of
saturated ammonium sulphate solution. After 15 mins, the
suspension was spun at 30,0006 g for 20 min. The pellet was
stored in 20uC, if not processed immediately.
Purification of untagged PPK
The ammonium sulphate pellet was suspended in appropriate
volume of Buffer A and loaded onto 8 ml Mono-Q column
(Amersham Life Sciences) equilibrated with 10 column volumes
(80 ml) of Buffer A. Following a wash with 3 column volumes of
buffer A, the protein of interest was eluted with 10 column
volumes of Buffer B (Buffer A+1M NaCl-Linear gradient) and the
peak fractions were pooled. Protein yields were estimated by
Bradford’s method and purity was checked by SDS-PAGE. The
purified PPK was then aliquoted and stored in 270uC.
Purification of His-tagged PPK
The ammonium sulphate pellet was suspended in an appropri-
ate volume of Buffer C (50 mM NaH2PO4,10 mM imidazole -
pH=8.0) to get a protein concentration of 1–2 mg/ml. The
suspension was spun at (48,5006 g) and NaCl was added till
conductance was identical to Buffer D (50 mM NaH2PO4,2 0m M
imidazole, 300 mM NaCl, pH=8.0). It was then loaded onto Ni–
NTA Hi-trap (Qiagen) column that had been pre-equilibrated
with 10 column volumes of Buffer D. The column was washed
with 3 column volumes of buffer D and eluted with Buffer E
(50 mM NaH2PO4, 300 mM NaCl, 300 mM imidazole,
pH=8.0). The eluted fraction was dialysed overnight against
Buffer F (50 mM Tris pH=7.5,10 mM KPO4 - pH-7.0, 4 mM
MgCl2, 1 mM PMSF, 20% glycerol). Protein yields were estimated
by Bradford’s method and purity was checked by SDS-PAGE.
The purified PPK was then aliquoted and stored in 270uC.
Taguchi optimization for PPK activity
In order to standardize the activity of M.tu PPK, it is essential to
identify the condition under which the activity is optimum. The
standard parameters that one optimizes for activity are the PolyP,
concentration of Mg
2+, NaCl and NH4SO4. Instead of the
standard two variable checkerboard strategies, we have used the
multiparametric Taguchi methods for optimization [26]. Though
this powerful statistical method has been successfully used for
optimization of PCR conditions [27], it does not find any other
mention in classical enzymology. To determine the optimum
conditions for the four parameters we need to do nine individual
experiments. The conditions for each variable chosen is a
‘guesstimate’ so that the optimum condition would probably lie
between the maximum and the minimum value of the variable.
The velocity of the enzyme reaction in each experiment was used
to estimate the effect of each component on the enzyme reaction.
This was done by using a quadratic loss function given by the
equation
SNL~{10 1=n
X n
i~1
1
 
vi2   
()
Where vi is the velocity of the reaction in the ith experiment.
SNL is plotted against each component, and the optimum reaction
conditions were chosen by identifying the value of the component
which maximized SNL according to the polynomial regression
curve, y=mx + nx
2 (Figure S1).
Assay for PPK activity
PPK activity (ATP-driven PolyP synthesis) was determined at
37uC by detecting PolyP formation. The assay mixture (30 ul)
consisted of 50 mM Tris-HCl pH-7.5, 10 mM NH4SO4,10 mM
KPO4,pH-7.0,4 mM MgCl2, 50 mM NaCl, 150 uM ATP and
40 nM Type 6 PolyP (Sigma). Each of the reactions (30 ul) were
terminated by adding to 270 ul of Toluidine blue and the
absorption ratio (530/630) nm was calculated in each case. To
overcome product inhibition by ADP formed during the PPK
reaction, 6 mM PEP and 10 U of pyruvate kinase was included in
the assay mix to bring about ATP regeneration [14,18,28]. The
reaction was initiated by the addition of the enzyme (0.5 ug) and
incubated at 37uC for 10 min. The increase in polyP concentra-
tion was then determined by the method outlined below. The
kinetic parameters, Km and Vmax were determined by conduct-
ing the assay in triplicate at 6 different ATP concentrations. The
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Luciferase assay (Text S2).
Determination of PolyP formed during assay of PPK by
metachromasy
PPK activity was monitored by the metachromatic shift. This
method is based on the shift in the absorbance maxima of the basic
dye Toluidine blue from 630 nm to 530 nm when PolyP or any
polyanion binds to the dye. As the polyanionic charge increases,
there is a concomitant increase in the magnitude of the
metachromatic shift [14,28,29]. For quantifying the amount of
PolyP formed, the entire assay mix (30 ul) was added to 270 ul of
dye solution (6 ug/mL Toluidine blue in 50 mM acetate buffer
pH-5.5). The metachomatic shift was monitored by a wavelength
scan from 500 to 700 nm. The resultant absorption spectra
revealed the presence of an Isosbestic Point - a wavelength at
which two or more components have the same extinction co-
efficient. The absorbance at isosbestic point can be used to
determine the total concentration of the two components which
could predictably be the two forms of toluidine blue – the PolyP-
bound Toluidine blue – [b] and the unbound Toluidine blue - [u].
The concentration of each of forms was determined using the
generic formula [30].
u ½  = b ½  ~ eb
630AisoeisoA630
    
eisoA630{eu
630Aiso
  
b ½  z u ½  ~ Aiso=eiso
Thus, knowing the concentration of bound dye molecule, the
concentration of PolyP can be determined by dividing the former
with the stoichiometric factor (binding ratio).
Determination of binding constant of Toluidine blue to
PolyP
To evaluate the binding constant (Ka) between polyP of various
length (P6, P25, P45 and P65) and Toluidine blue, concentration
of PolyP was varied while the dye was kept constant. The
association constant Ka = [PB]/[P] [B], where PB is the
concentration of polyphosphate bound dye while P and B free
polyphosphate and dye concentrations. By simple transposition we
have the equation: {[PB] + [B]}/[B] =1+ Ka [P].
Thus in an experiment where the concentration of Toluidine
blue is kept fixed and the polyphosphate concentration varied if we
plot Btotal/Bfree vs [P] we would get a straight line where the slope
would give Ka. The intercept of one is a diagnostic of the binding
which would indicate a one to one stoichiometry between PolyP
and the dye.
Direct measurement of ADP formation by PPK through
HPLC-Reverse-Phase Chromatography
The substrate ATP and the product ADP were separated on a
C-18-silica column using a binary gradient of Methanol and the
ion pairing agent TBAHS (10 mM, pH=6) as the mobile phase,
50 ul volume of standard PPK reaction was injected and
separation monitored at 260 nm at a flow-rate of 1 ml/min.
Run-time was 30 minutes. Prior to HPLC analysis, different
concentrations of ADP were run and a standard curve was
plotted – Area under the peak against amount of ADP. Using this
curve, the amount of ADP in the assay samples was determined.
The conditions for the assay was the same except for the
omission of the ATP-regenerating system (PEP and Pyruvate
kinase).
Evaluating product inhibition by Progress Curve
Many enzymes are inhibited by their product and hence initial
velocity measurement is the method of choice for evaluating the
kinetic constants [31]. Since progress curve goes into the relatively
late phase of the reaction where substantial product is already
formed the kinetics gets modified and simplified analysis by
progress curve may become erroneous. However when the
product inhibition is significant and suitable continuous kinetic
assay are unavailable, initial velocity measurements that are
devoid of product inhibition are difficult to perform. We can then
use the modified form of progress curve that takes product
inhibition into account.
Now, v/Vm= S/(S+Km) is the standard form of the MM
equation. We have, v= dp/dt where p is the product; also the
substrate conc. at time t is S and the initial conc is s
hence S= s-p.
Using these changes the differential form of the MM equation is
given by dp=dt~Vm s{p ðÞ = Kmzs{p ðÞ or, Kmzs{p ðÞ = f
s{p ðÞ g dp~Vmdt.
Inpresenceof productinhibition,sincethe product competes with
the substrate we can substitute Km by Km 1zp
 
Kp
  
or,
Km 1zp
 
Kp
  
zs{p
    
s{p ðÞ
  
dp~Vmdt or, Kmdp= s{p ðÞ
z Km=Kp
  
pdp
 
s{p ðÞ zdp~Vmdt.
Integrating we have: Km
Ð
dp
 
s{p ðÞ z Km
 
Kp
   Ð
pdp
 
s{p ðÞ z
Ð
dp~Vm
Ð
dt or, {Km ln s{p ðÞ z Km
 
Kp
  
s{ f
p{sln s{p ðÞ g zp~VmtzC...1 at t=0 p=0 thus using these
boundary conditions we have, substituting the value of C in eqtn1
we have: {Km ln s{p ðÞ z Km
 
Kp
  
s{p{sln s{p ðÞ fg zp~
Vm t{Kmln s ðÞ z Km
 
Kp
  
s{sln s ðÞ fg or, Km lns= s{p ðÞ z
Km
 
Kp
  
s lns= s{p ðÞ zp1 {Km
 
Kp
  
~Vmt or, Km 1zs
   
KpÞlns
 
s{p ðÞ zp1 {Km
 
Kp
  
~Vmt.
Transposing t= lns= s{p ðÞ ½  ~ 1=Vm ðÞ 1{Km=Kp
  
p
 
lns= s ð ½
{pÞ zKm(1zs=Kp)
 
Vm .........2. Thus plotting p= lns= ½
s{p ðÞ   vs t= lns= s{p ðÞ ½  will give a straight line with a slope of
1
 
1=Vm ðÞ 1{Km
 
Kp
  
and intercept {Km 1zs
 
Kp
    
Vm.
This indicates that at various values of s we will have parallel lines
variable intercepts.
Since the values of Km, Vm and s are known, the value of Kp
can be accurately estimated.
An experiment was designed wherein assay was done at
different substrate concentrations for different time intervals.
The assay product was analyzed by HPLC. From this data, p and
s-p values were calculated and required graphs plotted.
Assay for reverse PPK activity
PolyP-driven ATP synthesis of PPK was detected at 37uCb y
monitoring the formation of ATP using HPLC. The conditions
used were same as that used for the forward reaction (PolyP
synthesis). The assay-mix consisted of 50 mM Tris-HCl pH-7.5,
10 mM NH4SO4, 10 mM KPO4, pH-7.0, 4 mM MgCl2,5 0m M
NaCl, 400 uM ADP and 5.5 uM Type 75 PolyP (Sigma). The
assay was done for 5 mins at 37uC with the reaction being stopped
by the addition of 5 mM EDTA and 50 ul of the assay-mix was
injected onto the column.
Amount of the product formed was calculated from an ATP
standard curve and Km for ADP was determined by monitoring
the assay at different ADP concentrations.
Determination of oligomeric structure of PPK
Size-exclusion chromatography was used to measure the
oligomeric nature of PPK. About 200 ug of purified PPK was
loaded onto Superose-6 (HR-Amersham Pharmacia) equilibrated
with Buffer G (50 mM Tris-pH=7.5, 150 mM NaCl, 4 mM
Polyphosphate Kinase in Mtu.
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(BioRad).
Supporting Information
Text S1 Determination of oligomeric structure of PPK: Size-
exclusion chromatography was used to measure the oligomeric
nature of PPK. About 200 mg of purified PPK was loaded onto
Superose-6 (HR-Amersham Pharmacia) equilibrated with Buffer
G (50 mM Tris-pH=7.5, 150 mM NaCl, 4 mM MgCl2 and 10%
glycerol) along with protein MW standards (BioRad).
Found at: doi:10.1371/journal.pone.0014336.s001 (0.86 MB TIF)
Text S2 Assay for PPK activity by Luciferin-Luciferase method
Found at: doi:10.1371/journal.pone.0014336.s002 (0.77 MB TIF)
Figure S1 PPK activity. Effects of reaction components on the
activity of PPK as determined by polynomial regression. The
signal here represents the 530/630 ratio. An average of the ratios
was taken for each reaction component at each level of
concentration tested. The assay was done based on an orthogonal
array (total of 9 different reactions).
Found at: doi:10.1371/journal.pone.0014336.s003 (0.63 MB TIF)
Figure S2 Determination of Optimum pH for Mtu PPK. Using
the metachromatic assay, the optimum pH for PPK activity was
determined by doing the assay with 50 mM Tris. The 530/630
ratio is plotted against pH. The assay was done with 1.2 mgo f
purified PPK at 37uC for 10 min.
Found at: doi:10.1371/journal.pone.0014336.s004 (0.56 MB TIF)
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